IP Library Granted Patent US 10,960,057
Granted Patent B2
US 10,960,057 · App. 14/412,191 · Granted Mar 30, 2021

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

Inventors: Brian Cornblatt (Westminster, MD); Grace Cornblatt (Westminster, MD); Anton Bzhelyansky (Baltimore, MD); Robert Henderson (Street, MD)
Assignee: NUTRAMAX LABORATORIES, INC.
A61K38/47A23L33/105A61K9/0053A61K9/14A61K9/28A61K31/19A61K31/194A61K31/26A61K31/357A61K31/375A61K31/7028A61K31/716A61K33/06A61K36/06A61K36/07A61K36/28A61K36/31A61K45/06A61K47/42A61P3/06C12Y302/01147A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,057
App. No.
14/412,191
Granted
Mar 30, 2021
Kind
B2
Abstract

The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The invention also relates to the combination of sulforaphane or a derivative thereof and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present invention also relates to the combination of a broccoli extract or powder and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present provides compositions and methods relating to these combinations.

Claims (9)

1. An orally administrable composition comprising a broccoli extract or powder and one or both of a maitake and a shiitake mushroom extract or powder, the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and a sulforaphane precursor and one or more glucans, wherein the one or both of the sulforphane and the sulforaphane precursor and one or more glucans are provided to a subject in need thereof in amounts synergistically effective to at least increase levels and/or gene expression of NAD(P)H:quinone oxidoreductase 1 (NQO-1).

2. The orally administrable composition of claim 1 , wherein the broccoli extract or powder comprises glucoraphanin in an amount of about 1 to about 75% w/w.

3. The orally administrable composition of claim 1 , wherein the broccoli extract or powder comprises myrosinase.

4. The orally administrable composition of claim 1 , further comprising an enzyme potentiator.

5. The orally administrable composition of claim 1 , wherein the enzyme potentiator comprises ascorbic acid.

6. The orally administrable composition of claim 1 , wherein the composition comprises an enteric dosage form.

7. The orally administrable composition of claim 1 , comprising a maitake mushroom extract or powder comprising beta-glucan.

8. The orally administrable composition of claim 1 , comprising a shiitake mushroom extract or powder comprising alpha-glucan.

9. The orally administrable composition of claim 1 , comprising a maitake mushroom extract or powder and a shiitake mushroom extract or powder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2015
From: CORNBLATT, BRIAN; CORNBLATT, GRACE; BZHELYANSKY, ANTON; HENDERSON, ROBERT
To: NUTRAMAX LABORATORIES, INC.
Reel/Frame 035558/0773 →
Continuity (8)
Provisional Application 61668328 · Jul 5, 2012
Provisional Application 61668342 · Jul 5, 2012
Provisional Application 61668386 · Jul 5, 2012
Provisional Application 61668396 · Jul 5, 2012
Provisional Application 61668364 · Jul 5, 2012
Provisional Application 61668374 · Jul 5, 2012
Provisional Application 61794417 · Mar 15, 2013
Related Publication 20150147352A1 · May 28, 2015
Cited By (1)
US 12,648,979